Treatment outcome of chronic hepatitis C in sickle cell disease and thalassemic patients with interferon and ribavirin

European Journal of Gastroenterology and Hepatology

Volumn 22, Issue 1, 2010, Pages 123-124

  Alavian, Seyed Moayed ^a   Tabatabaei, Seyed Vahid ^a  

^a BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

DEFERASIROX; HEMOGLOBIN; HYDROXYUREA; INTERFERON; IRON; PEGINTERFERON; RIBAVIRIN;

ANEMIA; CHRONIC HEPATITIS; COMBINATION CHEMOTHERAPY; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG SAFETY; GENOTYPE; HEMOGLOBIN BLOOD LEVEL; HEPATITIS C; HUMAN; IRON BLOOD LEVEL; IRON CHELATION; LETTER; PHLEBOTOMY; PRIORITY JOURNAL; SICKLE CELL ANEMIA; THALASSEMIA; TREATMENT RESPONSE;

ANEMIA, SICKLE CELL; ANTIVIRAL AGENTS; BETA-THALASSEMIA; DRUG THERAPY, COMBINATION; HEPATITIS C, CHRONIC; HUMANS; INTERFERONS; RIBAVIRIN; TREATMENT OUTCOME;

EID: 74349100682     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MEG.0b013e32832e0a66     Document Type: Letter

References (7)

1. Ancel D, Amiot X, Chaslin-Ferbus D, Hagege I, Garioud A, Girot R, et al. Treatment of chronic hepatitis C in sickle cell disease and thalassaemic patients with interferon and ribavirin. Eur J Gastroenterol Hepatol 2009 (in press).
2. Alavian SM, Tabatabaei SV. Treatment of chronic hepatitis C in polytransfused thalassemic patients: a meta-analysis. J Viral Hepat 2009 (in press).
3. Hassan M, Hasan S, Castro O, Giday S, Banks A, Smoot D. HCV in sickle cell disease. J Natl Med Assoc 2003; 95:864-867. 872-874.
4. Conjeevaram HS, Fried MW, Jeffers LJ, Terrault NA, Wiley-Lucas TE, Afdhal N, et al. Peginterferon and ribavirin treatment in African American and Caucasian American patients with hepatitis C genotype 1. Gastroenterology 2006; 131:470-477. (Pubitemid 44142464)
5. Alavian SM. Are the real HCV infection features in Iranian patients the same as what is expected? Hepatitis Monthly 2005; 5:3-55.
6. Taher AT, Musallam KM, Khalife M, Barada K. Hepatitis C antiviral response in thalassemia: what is the role of liver iron concentration? Ann Hematol 2009 (in press).
7. Desai TK, Jamil LH, Balasubramaniam M, Koff R, Bonkovsky HL. Phlebotomy improves therapeutic response to interferon in patients with chronic hepatitis C: a meta-analysis of six prospective randomized controlled trials. Dig Dis Sci 2008; 53:815-822.